GHF-GOLDEN HEART FLOWER

General Data

Reg Number
516280682
Sector
Biomed
Established
2020
No. of Employees
10
Stage
R&D
Additional Funding
0

Technology

GHF developing disease-modifying medicines for glycogen storage diseases, lysosomal storage diseases and more.

Targeted Customers

Physicians, People with glycogen and lysosomal storage diseases.

Management personnel

Yaniv Glazer - CEO

Contact information

Name
Website
http://WWW.GHF-PHARMA.COM
Country
Israel
Zip
1857107

Tags

Life SciencesMedTechPharmaceuticals

Classified Technologies

Biotechnology and industrial biology

Winning details

Route name
Winning year

Seed Investment Program
Seed Investment Program
2023